Appeals and Complaints
Articles are licensed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0) (https://creativecommons.org/licenses/by/4.0/legalcode), which allows the open distribution and reproduction in any means, provided that the work is perfectly cited.
Lifescience Global follows the double-blind peer-review method for submissions of all manuscripts to its journals. It is the kind of peer-reviewing in which the identity of the authors and reviewers is not revealed in the submitted manuscript.
All submitted articles are subject to an extensive peer-review consultation with the Journal's Editorial Board and independent external referees. All manuscripts are evaluated rapidly and the decision taken by the Journal's Editor-in-Chief based on all the peer-reviewers' comments, which are then communicated to the author(s).
Submissions from the Editor-in-Chief and Editorial Board Members will deal with free peer-review and be presented to diverse editors to determine acceptance.
All efforts are performed to expedite the peer-review process leading to timely publication.
Authors publishing with Lifescience Global retains the copyright to their work.
Authors have the flexibility to publish a wide range of articles in Lifescience Global journals, e.g., short communications, full-length research and review articles, as well as supplements, conference proceedings, and case studies.
Human and Animal Rights: All clinical studies must be managed according to the Declaration of Helsinki principles. For all manuscripts publishing data from studies including human participants, formal review and approval by a relevant institutional review board or ethics committee are needed.
For research concerning animals, the authors should indicate whether the methods followed were under the standards described in the eighth edition of Guide for the Care and Use of Laboratory Animals grants.nih.gov/grants/olaw/guide-for-the-care-and-use-of-laboratory-animals_prepub.pdf, published by the National Academy of Sciences, The National Academies Press, Washington, D.C.).
Research Involving Animals
- Research work on animals should be carried out following the NC3Rs ARRIVE Guidelines. For In Vivo Experiments, visit https://www.nc3rs.org.uk/arrive-guidelinesAuthors must prominently state the name of the support committee, highlighting that legal and ethical consent was taken before starting the research work carried out on animals and that attended the experiments according to the relevant guidelines and regulations stated below.
- US authors should cite compliance with the US National Research Council's "Guide for the Care and Use of Laboratory Animals."
- The US Public Health Service's "Policy on Humane Care and Use of Laboratory Animals" and "Guide for the Care and Use of Laboratory Animals"
- UK authors should conform to UK legislation under the Animals (Scientific Procedures) Act 1986 Amendment Regulations (SI 2012/3039).
- European authors outside the UK should conform to Directive 2010/63/EU.
- Research in animals must adhere to ethical guidelines of The Basel Declaration.
- The manuscript must include a declaration of compliance with relevant guidelines (e.g., the revised Animals (Scientific Procedures) Act 1986 in the UK and Directive 2010/63/EU in Europe) and/or appropriate permissions or licenses obtained by the IUCN Policy Statement on Research Involving Species at Risk of Extinction and the Convention on the Trade in Endangered Species of Wild Fauna and Flora.
Research Involving Plants:
All experimental research on plants (either cultivated or wild) must comply with international guidelines. The manuscript must indeed include a declaration of compliance of field studies with relevant guidelines and/or relevant permissions or licenses obtained by the IUCN Policy Statement on Research Involving Species at Risk of Extinction and the Convention on the Trade in Endangered Species of Wild Fauna and Flora.
Compliance with the guidelines of the International Committee of Medical Journal Editors (http://www.icmje.org/) is recommended, following the patient's consent for research or participation in a study for Lifescience Global as per the applicable laws and regulations regarding the privacy and/or security of personal information, including, but not limited to, the Health Insurance Portability and Accountability Act of 1996 ("HIPAA") and other U.S. federal and state laws relating to confidentiality and security of personally distinguishable evidence, the General Data Protection Regulation (GDPR) (EU) 2016/679 and member state implementing legislation, Canada's Personal Information Protection and Electronic Documents Act, India's Information Technology Act and related Privacy Rules, (together "Data Protection and Privacy Laws").
It is the responsibility of the author to ensure that:
- Must not be mentioned patients' names, initials, or hospital numbers anywhere in the manuscript (including figures).
- Authors are responsible for obtaining patient consent-to-disclose forms for all recognizable patients in videos, photographs, or other information that may be published in the journal, in the acquired study, or on the journal's website and for presenting the manuscript to the recognizable patient for review before submission.
- The consent-to-disclose form should indicate specific use (publication in the medical literature in print and online, knowing that patients and the public will have passage) of the patient's information and images in figures or videos. It must contain the patient's signature or that of a legal guardian, along with a statement that the patient or legal guardian has been offered the opportunity to review the identifying materials and the accompanying manuscript.
- Suppose the manuscript has an individuals' data, such as personal detail, audio-video material, etc.; In that case, permission should be gained from that individual. In the case of children, consent should be obtained from the parent or the legal guardian.
- Must make a specific declaration of such approval and consent-to-disclose form in the copyright letter and a stand-alone paragraph at the end of the article, especially in the case of human studies where inclusion of a statement regarding obtaining the written informed consent from each subject or subject's guardian is a must. The guarantor or corresponding author should retain the original. Editors may request to provide the original forms by fax or e-mail.
- Proper consent should follow all such case reports before publishing.
Editors may request that authors provide documentation of the formal review and recommendation from the institutional review board or ethics committee responsible for oversight of the study. The editors reserve the right to reject manuscripts that do not comply with the requirements mentioned earlier. The author will be held responsible for false statements or failure to fulfill the criteria mentioned above.
Non-identifiable Images: Anonymous images that do not identify the individual directly or indirectly, such as through any identifying marks or text, do not require formal consent, for example, x-rays, ultrasound images, pathology slides, or laparoscopic images.
If not obtaining consent, concealing the identity through eye bars or blurring the face would not be acceptable.
Appeals and Complaints: Generally, the editorial decisions are not reverted. However, authors who consider that their manuscript was rejected due to a misunderstanding or mistake may seek an explanation for the decision. Appeals must give sound reasoning and compelling evidence against the criticism raised in the rejection letter. A difference of opinion as to the interest, novelty, or suitability of the manuscript for the journal will not be considered an appeal. The EIC and other relevant editors will consider the request. The decision after that taken by the journal will be deemed final. Acceptance of the manuscript is not guaranteed even if the journal agrees to reconsider the manuscript. The reconsideration process may involve previous or new reviewers or editors and substantive revision.
Plagiarism Prevention: Lifescience Global uses the iThenticate software to detect instances of overlapping and similar text in submitted manuscripts. iThenticate software checks the content against a database of periodicals, the Internet, and a comprehensive article database. It generates a similarity report, highlighting the percentage overlap between the uploaded article and the published material. Any instance of content overlap is further examined for suspected plagiarism according to the publisher's Editorial Policies. Lifescience Global allows an overall similarity of 20% for a manuscript to be acknowledged for publication. The similarity percentage is further checked keeping the following important points in view:
Low Text Similarity: The text of every submitted manuscript is examined using the Content Tracking mode in iThenticate. This mode ensures that manuscripts with an overall low percentage similarity (but which may have a higher similarity from a single source) are not neglected. The acceptable limit for similarity of text from a single source is 5%. Suppose the similarity level is above 5%. In that case, the manuscript is returned to the author for paraphrasing the text and citing the source of the copied material.
It is essential to mention that the text taken from different sources with an overall low similarity percentage will be considered plagiarized content if most of the article is a combination of copied material.
High Text Similarity: There may be some manuscripts with an overall low similarity percentage but a higher percentage from a single source. A manuscript may have less than 20% overall similarity, but 15 % similar text is taken from a single article. The similarity index in such cases is higher than the approved limit for a single source. Authors are encouraged to thoroughly rephrase the similar text and properly cite the original quote to bypass plagiarism and copyright violation.
Types of Plagiarism: We all understand that scholarly manuscripts are drafted after a careful review of previously published articles. It is therefore not easy to draw a clear boundary between legitimate representation and plagiarism. However, the following important features can assist in identifying different kinds of plagiarized content. These are:
- Reproduction of others' words, sentences, ideas, or findings as one's own without proper acknowledgment.
- Text recycling, also known as self-plagiarism. The author practices a former publication in the different paper without proper citation and acknowledgment of the original source.
- Poor paraphrasing, copying complete paragraphs and modifying a few words without changing the structure of original sentences or changing the sentence structure but not the words.
- Verbatim copying of text without placing quotation marks and not acknowledging the work of the original author.
- They are correctly citing a work but poorly paraphrasing the original text is considered unintentional plagiarism. Similarly, manuscripts with language between paraphrasing and quoting are not acceptable. Authors should either paraphrase properly or quote and, in both cases, cite the original source.
- Higher similarity in the abstract, introduction, materials and methods, and discussion and conclusion sections indicates that the manuscript may contain plagiarized text. Authors can easily explain these parts of the manuscript in many ways. However, author technical terms and sometimes standard methods cannot be rephrased; therefore, Editors must carefully review these sections before deciding.
Plagiarism in Published Manuscripts: Published manuscripts containing plagiarized text are retracted from the journal website after careful investigation and approval by the Journal's Editor-in-Chief. A 'Retraction Note' and a link to the original study are published on the plagiarised manuscript's electronic version.
Copyrights: Authors who publish in Lifescience Global journals retain copyright to their work. Submission of a manuscript to the respective journals implies that all authors have read and agreed to the content of the Covering Letter or the Terms and Conditions. It is a condition of publication that manuscripts submitted to a journal have not been published and will not be simultaneously submitted or published elsewhere.
Lifescience Global (Licensor) grants the author(s) a worldwide, royalty-free, non-exclusive, and non-commercial perpetual license to exercise the rights in the article published as stated below:
- All articles are published under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/legalcode), which permits free distribution and reproduction in any medium that the work is properly cited.
- The authors retain the copyright of their published article. They will also have the right to:
- Reproduce the article, to incorporate the article into one or more collective works, and to reproduce the article as incorporated in collective works;
- Create and reproduce Derivative Works for educational purposes.
- Distribute Copies
- Any commercial application of the work, with prior agreement by the author, is exclusively granted to Lifescience Global.
Waiver: Authors grant to Lifescience Global (licensor) the right to retain all revenue from commercial sales of the author's published article in Lifescience Global journals.
Lifescience Global gives affordable article processing fees, standing amongst the most economical matched to other OPEN access journal publishers. An article-processing fee obligatory by the author/author's institution practices for every accepted article to cover the costs incurred by OPEN access publication.
Authors can self-archive post prints of their listed articles.
Authors can reproduce derivative works of the article for educational purposes and distribute its copies.
Publication Charges Policy: Lifescience Global is committed to disseminating research and scholarly publications as widely as possible. It supports the principle that 'the study results that have been publicly funded should be freely accessible in the public domain. Therefore, it encourages researchers to make their research available through Open Access (OA).
Open access publishing is not without costs. Lifescience Global provides open access publications partly pay the expenses of journal production, online hosting, and archiving from authors and their research supporters by charging a publication fee for each article they publish.
Errata, Corrigenda, and Corrections in Published Articles: Authors and readers are advised to notify the Editor-in-Chief if they discover errors in published content, author's names, and affiliations or if they have reasons for concern over the legitimacy of a publication. In such cases, Lifescience Global will publish an ERRATUM or a CORRIGENDUM, in discussion with the Editor-in-Chief and authors of the article, and/or substitute or retract the article.
Article Withdrawal: Article(s) that have been accepted for publication but which have not been published with volume/issue/page information) that include errors or are determined to violate the publishing ethics guidelines such as multiple submission, fake claims of authorship, plagiarism, fraudulent use of data, or the like, maybe "Withdrawn" from the journal. Withdrawal means that the article files are removed and replaced with a PDF stating that the article has lived removed from the following Journal Lifescience Global.
Article Retraction: If any manuscripts are published, having certain assigned information of volume/issue/page number, and it is found that there are infringements of professional, ethical codes in their content, such as plagiarism, excess similarity with some other article, fraudulent use of data, etc., then such manuscripts are retracted.
A retraction note entitled "Retraction: [article title]" (for example, Retraction: ABC experiment involving XYZ species) is published in the paginated part of the next scheduled issue of the journal and is also listed in the table of contents.
- They have clear evidence that the findings are unreliable, either as a result of major error (eg, miscalculation or experimental error), or as a result of fabrication (eg, of data) or falsification (eg, image manipulation)
- It constitutes plagiarism
- The findings have previously been published elsewhere without proper attribution to previous sources or disclosure to the editor, permission to republish, or justification (ie, cases of redundant publication)
- It contains material or data without authorisation for use
- Copyright has been infringed or there is some other serious legal issue (eg, libel, privacy)
- It reports unethical research
- It has been published solely on the basis of a compromised or manipulated peer review process
- The author(s) failed to disclose a major competing interest (aka, conflict of interest) that, in the view of the editor, would have unduly affected interpretations of the work or recommendations by editors and peer reviewers.
Concurrent Publication/Simultaneous Submission: It is a condition of publication that manuscripts submitted to the Lifescience Global journal have not been published and will not be simultaneously submitted or published elsewhere. Plagiarism is strictly forbidden, and by submitting the article for publication, the authors agree that the publishers have the legal right to take appropriate action against the authors if plagiarism or fabricated information is discovered.
Abstracts and posters of conferences, results presented at meetings (for example, to inform investigators or participants about findings), results from databases (data without interpretation, discussion, context, or conclusions in the form of tables and text to describe data/information where this is not easily presented in tabular form) are not considered before publication.
Authors who wish to publish translations of the articles that have been published elsewhere should ensure that they have appropriate permission(s), indicate clearly that the material has been translated and re-published, and show the primary source of the material. The Editor-in-Chief may request the related publications if he/she is concerned about overlap and possible redundancy.
Disclaimer: Responsibility for the content published by Lifescience Global in any of its journals, including any opinions expressed therein, rests exclusively with the author(s) of such content. To the maximum extent permitted by applicable law, Lifescience Global (on its behalf and behalf of its staff and members of its editorial board) disclaims responsibility for any injury and/or damage (whether financial or otherwise) to persons or property, resulting directly or indirectly from any ideas, methods, instructions, or products (including errors in the same) referred to in any content of Lifescience Global journals. Any dispute arising, including any claim, shall be governed exclusively by the laws of Mississauga, Canada.